RA CAPITAL MANAGEMENT, L.P. - 02 Apr 2024 Form 4 Insider Report for Boundless Bio, Inc. (BOLD)

Role
10%+ Owner
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Issuer symbol
BOLD
Transactions as of
02 Apr 2024
Net transactions value
+$5,000,000
Form type
4
Filing time
04 Apr 2024, 16:15:15 UTC
Previous filing
29 Mar 2024
Next filing
15 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BOLD Common Stock Conversion of derivative security +1,587,912 1,587,912 02 Apr 2024 See footnotes F1, F2, F3
transaction BOLD Common Stock Purchase $4,750,000 +296,875 +19% $16.00* 1,884,787 02 Apr 2024 See footnotes F2, F3
transaction BOLD Common Stock Conversion of derivative security +280,219 280,219 02 Apr 2024 See footnotes F1, F3, F4
transaction BOLD Common Stock Purchase $250,000 +15,625 +5.6% $16.00* 295,844 02 Apr 2024 See footnotes F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BOLD Series B Preferred Stock Conversion of derivative security $0 -17,000,000 -100% $0.000000* 0 02 Apr 2024 Common Stock 871,794 See footnotes F1, F2, F3
transaction BOLD Series B Preferred Stock Conversion of derivative security $0 -3,000,000 -100% $0.000000* 0 02 Apr 2024 Common Stock 153,846 See footnotes F1, F3, F4
transaction BOLD Series C Preferred Stock Conversion of derivative security $0 -13,964,285 -100% $0.000000* 0 02 Apr 2024 Common Stock 716,118 See footnotes F1, F2, F3
transaction BOLD Series C Preferred Stock Conversion of derivative security $0 -2,464,286 -100% $0.000000* 0 02 Apr 2024 Common Stock 126,373 See footnotes F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

RA CAPITAL MANAGEMENT, L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 On April 2, 2024, each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock on a 19.5-for-1 basis immediately prior to the closing of the Issuer's initial public offering. The shares of Series B Preferred Stock and Series C Preferred Stock had no expiration date.
F2 Held directly by RA Capital Healthcare Fund, L.P. (the "Fund").
F3 RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
F4 Held directly by the Nexus Fund II.